Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Metastatic Colorectal Cancer (BRECOL)

This study is currently recruiting participants. (see Contacts and Locations)

Verified June 2013 by Spanish Breast Cancer Research Group

Sponsor:

Collaborator:

Roche Farma, S.A

Information provided by (Responsible Party):

Spanish Breast Cancer Research Group

ClinicalTrials.gov Identifier:

NCT01733628

First received: November 20, 2012

Last updated: June 7, 2013

Last verified: June 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2015
Estimated Primary Completion Date:	December 2013 (Final data collection date for primary outcome measure)